Host microbiota

The **host microbiota** refers collectively to all resident microorganisms—bacteria, archaea, fungi, viruses—that inhabit various surfaces and cavities within a multicellular host organism such as humans. These communities are found on skin and mucosal surfaces including the gut, oral cavity, respiratory tract, urogenital tract and more. The relationship between host and its resident microbes is complex: while some members are commensal or mutualistic—providing benefits like nutrient processing or immune education—others may be pathogenic under certain conditions[1][2]. The human body harbors trillions of these organisms which play essential roles in digestion/absorption processes,[4] synthesis of vitamins/metabolites,[3] protection against invading pathogens through colonization resistance,[1] shaping immune responses,[2] maintaining tissue homeostasis,[3] and even influencing neurodevelopment.[1] Disruptions in this balanced ecosystem—a state known as dysbiosis—are associated with increased susceptibility to infections,[4] chronic inflammation,[2], metabolic disorders and possibly cancer.[3] While not itself a druggable molecular target like an enzyme or receptor protein—and thus not considered a therapeutic target per se—the concept is central to emerging therapies aimed at restoring healthy microbial balance using probiotics/prebiotics/fecal transplants. Because "host microbiota" does not refer to any single molecule/protein/receptor but rather an entire ecological community within the host organism's body—and because it cannot be targeted by small molecules/antibodies in conventional pharmacological terms—it should not be classified alongside canonical drug targets such as receptors or enzymes.[1][2][4] In summary: **Host microbiota** is not itself a molecular therapeutic target but represents an important biological system whose modulation has significant implications for health and disease management.

Other names

MicrobiotaNormal microbiotaResident microbiotaCommensal microbiotaHuman microbiome (sometimes used interchangeably, though technically refers to the collective genomes)

Not applicable for "host microbiota" as a molecular target. For drugs affecting the host-microbiome interface, mechanisms include alteration of microbial composition, suppression or promotion of specific taxa, restoration after dysbiosis.